What to Know About the RSV Treatment Shortage

A recently approved treatment was supposed to protect babies from RSV, but demand is outpacing the supply of the medication. 

The U.S. Food and Drug Administration approved nirsevimab, an antibody that sticks to and prevents Respiratory Syncytial Virus from infecting cells, in July. The Centers for Disease Control and Prevention (CDC) then recommended the medication for all babies ei…

Read more